Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 6
Submit an article Journal homepage
289
Views
100
CrossRef citations to date
0
Altmetric
Research Article

Activity of a Novel Anti-folate (PDX, 10-propargyl 10-deazaaminopterin) against Human Lymphoma is Superior to Methotrexate and Correlates with Tumor RFC-1 Gene Expression

Eunice S. Wang Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021-6306, USA
,
Owen O'Connor Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021-6306, USA
,
Yuhong She Program of Molecular Pharmacology and Experimental Therapeutics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
,
Andrew D. Zelenetz Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021-6306, USA
,
F.M. Sirotnak Program of Molecular Pharmacology and Experimental Therapeutics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
&
Malcolm A.S. Moore Laboratory of Developmental Hematopoiesis, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Pages 1027-1035 | Published online: 01 Jul 2009

  • DeVita, V., Hellman, S. and Rosenberg, S. (2001) Cancer: Principles and Practice of Oncology. 6th ed. (Lippincott Williams and Wilkins, Philadelphia).
  • Howe, H.L., Wingo, P.A., Thun, M.J., Ries, L.A., Rosenberg, H.M., Feigel, E.G. and Edwards, B.K. (2001) "Annual report to the nation on the status of cancer (1973-1998), featuring cancers with recent increasing trends". J Natl Cancer Inst. 93, 824-842.
  • DeVita, V.T.J., Hellman, S. and Rosenberg, S.A., eds (1995) Biologic Therapy of Cancer (Lippincott Williams & Wilkins, Philadelphia).
  • Dhaliwal, H.S., Rohatiner, A.Z., Gregory, W., Richards, M.A., Johnson, P.W., Whelan, J.S., Gallagher, C.J., Matthews, J., Ganesan, T.S., Barnett, M.J., et al. (1993) "Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma". Br. J. Cancer 68, 767-774.
  • Dorigo, A., Mansberg, R. and Kwan, Y.L. (1993) "Lomustine, etoposide, methotrexate and prednisone (LEMP) therapy for relapsed and refractory non-Hodgkin's lymphoma". Eur. J. Haematol. 50, 37-40.
  • Sarris, A.H., Phan, A., Duvic, M., Romaguera, J., McLaughlin, P., Mesina, O., King, K., Medeiros, L.J., Rassidakis, G.Z., Samuels, B. and Cabanillas, F. (2002) "Trimetrexate in relapsed T-cell lymphoma with skin involvement". J. Clin. Oncol. 20, 2876-2880.
  • McGrath, I., Adde, M., Shad, A., Venzon, D., Seibel, N., Gootenber, J., Neely, J., Arndt, C., Neider, M., Jaffe, E., Wittes, R.A. and Horal, I.D. (1996) "Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen". J. Clin. Oncol. 12, 925-934.
  • DeGraw, J.I., Colwell, W.T., Piper, J.R. and Sirotnak, F.M. (1993) "Synthesis and antitumor activity of 10-propargyl-10-deazaaminopterin". J. Med. Chem. 36, 2228-2231.
  • Sirotnak, F.M., DeGraw, J.I., Moccio, D.M., Samuels, L.L. and Goutas, L.J. (1984) "New folate analogs of the 10-deazaaminopterin series. Basis for structural design and biochemical and pharmacologic properties". Cancer Chemother. Pharmacol. 12, 18-25.
  • Sirotnak, F.M., DeGraw, J.I., Schmid, F.A., Goutas, L.J. and Moccio, D.M (1984) "New folate analogs of the 10-deazaaminopterin series. Further evidence for markedly increased antitumor efficacy compared with methotrexate in ascitic and solid murine tumor models". Cancer Chemother. Pharmacol. 12, 26-30.
  • Schmid, F.A., Sirotnak, F.M., Otter, G.M. and DeGraw, J.I. (1985) "New folate analogs of the 10-deaza-aminopterin series: markedly increased antitumor activity of the 10-ethyl analog compared to the parent compound and methotrexate against some human tumor xenografts in nude mice". Cancer Treat. Rep. 69, 551-553.
  • Sirotnak, F.M., Schmid, F.A., Samuels, L.L. and DeGraw, J.I. (1987) "10-Ethyl-10-deaza-aminopterin: structural design and biochemical, pharmacologic, and antimmor properties". NCI Monogr. 5, 127-131.
  • Sirotnak, F.M., DeGraw, J.I., Colwell, W.T. and Piper, J.R. (1998) "A new analogue of 10-deaza-aminopterin with markedly enhanced curative effects against human tumor xenografts in mice". Cancer Chemother. Pharmacol. 42, 313-318.
  • Krug, L.M., Ng, K.K., Kris, M.G., Miller, V.A., Tong, W., Heelan, R.T., Leon, L., Leung, D., Kelly, J., Grant, S.C. and Sirotnak, F.M. (2000) "Phase 1 and pharmacokinetic study of 10-propargyl-10-deaza-aminopterin, a new antifolate". Clin. Cancer Res. 6, 3493-3498.
  • Pulvertaft, R. (1964) "Cytology of Burkitt's tumour (African lymphoma)". Lancet 1, 238-240.
  • Beckwith, M., Longo, D.L., O'Connell, C.D., Moratz, C.M. and Urba, W.J. (1990) "Phorbol ester-induced, cell-cycle-specific, growth inhibition of human B-lymphoma cell lines". J Natl Cancer Inst. 82, 501-509.
  • Amstein, P., Taylor, D.O., Nelson-Rees, W.A., Huebner, R.J. and Lennette, E.H. (1974) "Propagation of human tumors in antithymocyte serum-treated mice". J Natl Cancer Inst. 52, 71-84.
  • Ohsugi, Y., Gershwin, M.E., Owens, R.B. and Nelson-Rees, W.A. (1980) "Tumorigenicity of human malignant lymphoblasts: comparative study with unmanipulated nude mice, antilymphocyte serum-treated nude mice, and X-irradiated nude mice". J. Natl Cancer Inst. 65, 715-718.
  • Goy, A., Gilles, F., Remache, Y., Filippa, D., Portlock, C.S., Jhanwar, S.C. and Zelenetz, A.D. (2001) "Establishment of a human cell line (SKI-DLCL-1) with a t(1:14)(q21;q32) translocation from the ascites of a patient with diffuse large cell lymphoma". Leuk. Lymphoma 40, 419-423.
  • Gilles, F., Goy, A., Remache, Y., Shue, P. and Zelenetz, A.D. (2001) "MUCI dysregulation as the consequence of a t(1:14)(q21:q32) translocation in an extranodal lymphoma". Blood 95, 2930-2936.
  • Sirotnak, F.M., Wendel, H.G., Bornmann, W.G., Tong, W.P., Miller, V.A., Scher, H.I. and Kris, M.G. (2000) "Co-administration of probenecid, an inhibitor of a cMOAT/MRP-like plasma membrane ATPase, greatly enhanced the efficacy of a new 10-deazaaminopterin against human solid tumors in vivo". Clin. Cancer Res. 6, 3705-3712.
  • Khokhar, N.Z., She, Y., Rusch, V.W. and Sirotnak, F.M. (2001) "Experimental therapeutics with a new 10-deazaaminopterin in human mesothelioma: further improving efficacy through structural design, pharmacologic modulation at the level of MRP ATPases. and combined therapy with platinums". Clin. Cancer Res. 7, 3199-3205.
  • Eads, C.A., Danenberg, K.D., Kawakami, K., Saltz, L.B., Danenberg, P.V. and Laird, P.W. (1999) "CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression". Cancer Res. 59, 2302-2306.
  • Rots, M.G., Willey, J.C., Jansen, G., Van Zantwijk, C.H., Noordhuts, P., DeMuth, J.P., Kuiper, E., Veerman, A.J., Pieters, R. and Peters, G.J. (2000) "mRNA expression levels of methotrexate resistance-related proteins in childhood leukemia as determined by a standardized competitive template-based RT-PCR method". Leukemia 14, 2166-2175.
  • Shultz, L.D., Schweitzer, P.A., Christianson, S.W., Gott, B., Schweitzer, I.B., Tennent, B., McKenna, S., Mobraaten, L., Rajan, T.V., Greiner, D.L., et al. (1995) "Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice". J. Immunol. 154, 180-191.
  • Shultz, L.D., Lang, P.A., Christianson, S.W., Gott, B., Lyons, B., Umeda, S., Leiter, E., Hesselton, R., Wagar, E.J., Leif, J.H., Kollet, O., Lapidot, T. and Greiner, D.L. (2000) "NOD/LtSz-Rag I null mice: an immunodeficient and radio resistant model for engraftment of human hematolymphoid cells. HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells". J. Immunol. 164, 2496-2507.
  • Piacibello, W., Sanavio, F., Severino, A., Dane, A., Gammaitoni, L., Fagioli, F., Perissinotto, E., Cavalloni, G., Kollet, O., Lapidot, T. and Aglietta, M. (1999) "Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells". Blood 93, 3736-3749.
  • Kollet, O., Peled, A., Byk, T, Ben-Hur, H., Greiner, D., Shultz, L. and Lapidot, T. (2000) "Beta2 microglobulin-deficient (B2m(null)) NOD/SCID mice are excellent recipients for studying human stem cell function". Blood 95, 3102-3105.
  • Hudson, W.A., Li, Q., Le, C. and Kersey, J.H. (1998) "Xenotransplantation of human lymphoid malignancies is optimized in mice with multiple immunologic defects". Leukemia 12, 2029-2033.
  • Alizadeh, A.A., Eisen, M.B., Davis, R.E., Ma, C., Lossos, I.S., Rosenwald, A., Boldrick, J.C., Sabet, H., Tran, T., Yu, X., Powell, J.I., Yang, L., Marti, G.E., Moore, T., Hudson, J., Lu, L., Lewis, D.B., Tibshirani, R., Sherlock, G., Chan, W.C., Greiner, T.C., Weisenburger, D.D., Armitage, J.O., Warnke, R., Staudt, L.M., et al. (2000) "Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling". Nature 403, 503-511.
  • Shipp, M.A., Ross, K.N., Tamayo, P., Weng, A.P., Kutok, J.L., Aguiar, R.C., Gaasenbeek, M., Angelo, M., Reich, M., Pinkus, G.S., Ray, T.S., Koval, M.A., Last, K.W., Norton, A., Lister, T.A., Mesirov, J., Neuberg, D.S., Lander, E.S., Aster, J.C. and Golub, T.R. (2002) "Diffuse large B cell lymphoma outcome prediction by gene expression profiling and supervised machine learning". Nature Med. 8, 68-74.
  • Sierra, E.E. and Goldman, I.D. (1999) "Recent advances in the understanding of the mechanism of membrane transport of folates and antifolates". Semin. Oncol. 26, 11-23.
  • Kamen, B. (1997) "Folate and antifolate pharmacology". Semin. Oncol. 24, S18-30-S18-39.
  • Sirotnak, F.M. and Tolner, B. (1999) "Carrier-mediated membrane transport of folates in mammalian cells". Annu. Rev. Nutr. 19, 91-122.
  • Mauritz, R., Peters, G.J., Priest, D.G., Assaraf, Y.G., Drori, S., Kathmann, I., Noordhuis, P., Bunni, M.A., Rosowsky, A., Schornagel, J.H., Pinedo, H.M. and Jansen, G. (2002) "Multiple mechanisms of resistance to methotrexate and novel antifolates in human CCRF-CEM leukemic cells and their implications for folate homeostasis". Biochem. Pharmacol. 63, 105-115.
  • Lenz, H.J., Danenberg, K., Schnieders, B., Goeker, E., Peters, G.J., Garrow, T., Shane, B., Bertino, J.R. and Danenberg, P.V. (1994) "Quantitative analysis of folylpolyglutamate synthetase gene expression in tumor tissues by the polymerase chain reaction: marked variation of expression among leukemia patients". Oncol. Res. 6, 329-335.
  • Whitehead, V.M., Vuchich, M.I., Lauer, S.J., Mahoney, D., Carroll, A.J., Shuster, J.J., Esseltine, D.W., Payment, C., Look, A.T., Akabutu, J., et al. (1992) "Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (greater than 50 chromosomes) B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group study". Blood 80, 1316-1323.
  • Whitehead, V.M., Payment, C., Cooley, L., Lauer, S.J., Mahoney, D.H., Shuster, J.J., Vuchich, M.J., Bernstein, M.L., Look, A.T., Pullen, D.J. and Camitta, B. (2001) "The association of the TELAMI.I chromosomal translocation with the accumulation of methotrexate polyglutamates in lymphoblasts and with ploidy in childhood B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study". Leukemia 15, 1081-1088.
  • Gorlick, R., Goker, E., Trippett, T., Steinherz, P., Elisseyeff, Y., Mazumdar, M., Flintoff, W.F. and Bertino, J.R. (1997) "Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression". Blood 89, 1013-1018.
  • Rhee, M.S., Wang, Y., Nair, M.G. and Galivon, J. (1993) "Acquisition of resistance to antifolates caused by enhanced gamma-glutamyl hydrolase activity". Cancer Res. 53, 2227-2230.
  • Mantadakis, E., Smith, A.K. and Kamen, B.A. (2000) "Ratio of methotrexate to folate uptake by lymphoblasts in children with B-lineage acute lymphoblastic leukemia: a pilot study". J. Pediatr. Hematol. Oncol. 22, 221-226.
  • Ding, B.C., Whetstine, J.R., Witt, T.L., Schuetz, J.D. and Matherly, L.H. (2001) "Repression of human reduced folate carrier gene expression by wild type p53". J. Biol. Chem. 276, 8713-8719.
  • Drori, S., Jansen, G., Mauritz, R., Peters, G.J. and Assaraf, Y.G. (2000) "Clustering of mutations in the first transmembrane domain of the human reduced folate carrier in GW1843U89-resistant leukemia cells with impaired antifolate transport and augmented folate uptake". J. Biol. Chem. 275, 30855-30863.
  • Whetstine, J.R., Gifford, A.J., Witt, T. Liu, X.Y., Flatley, R.M., Norris, M., Haber, M., Taub, J.W., Ravindranath, Y. and Matherly, L.H. (2001) "Single nucleotide polymorphisms in the human reduced folate carrier: characterization of a high-frequency G/A variant at position 80 and transport properties of the His(27) and Arg(27) carries". Clin. Cancer Res. 7, 3416-3422.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.